Suppr超能文献

伊朗多发性硬化症患者的膀胱功能障碍

Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.

作者信息

Azadvari Mohaddeseh, Emami Razavi Seyede Zahra, Shahrooei Masumeh, Naser Moghadasi Abdorreza, Azimi Amirreza, Farhadi-Shabestari Hamid Reza

机构信息

Physical Medicine and Rehabilitation Department, Sina Hospital, Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Physical Medicine and Rehabilitation Department, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

J Multidiscip Healthc. 2020 Apr 2;13:345-349. doi: 10.2147/JMDH.S244697. eCollection 2020.

Abstract

BACKGROUND

Bladder dysfunction is one of the most disabling problems in multiple sclerosis patients, associated with lower quality-of-life and social isolation. There have been few studies regarding bladder dysfunction in Iranian patients with multiple sclerosis. Therefore, this study was designed to assess bladder dysfunction in Iranian patients with multiple sclerosis.

METHODS

This cross-sectional study was conducted in the MS Clinic of Sina Hospital (affiliated to Tehran University of Medical Sciences) between January 2019 and January 2020. Patients were asked to fill the valid and reliable Persian version of the 8-item Actionable Bladder Symptom Screening Tool (ABSST) questionnaire. Demographic data and accompanying symptoms such as fatigue, depression, anxiety, bowel dysfunction, urinary problems and walking status were recorded.

RESULTS

Two hundred and twenty-eight cases were enrolled. One hundred and eighty-three were female (80.3%) and 45 (19.7%) were male (F/M ratio=4). The mean ABSST score was 6.8±5.7. Based on the cut-off value of eight, 83 (28.8%) had actionable bladder symptoms (36.4%). The mean age and duration of the disease were significantly higher in the group with ABSST≥8. The number of patients with urinary retention, dribbling, and incontinence was significantly higher in the second group, while the number of individuals who could walk without help was significantly higher in the first group (ABSST<8). Logistic regression analysis by considering an ABSST score of less or more than 8 as dependent and age, sex, duration of the disease, marital status, education level, and BMI as independent variables showed that age, education level, and duration of the disease are independent predictors.

CONCLUSION

According to these results, nearly one-third of Iranian patients with MS suffer from an overactive bladder, which should be considered by physicians.

摘要

背景

膀胱功能障碍是多发性硬化症患者最致残的问题之一,与生活质量下降和社会隔离相关。关于伊朗多发性硬化症患者膀胱功能障碍的研究很少。因此,本研究旨在评估伊朗多发性硬化症患者的膀胱功能障碍。

方法

本横断面研究于2019年1月至2020年1月在德黑兰医科大学附属的西娜医院的多发性硬化症诊所进行。要求患者填写经过验证且可靠的波斯语版8项可行动膀胱症状筛查工具(ABSST)问卷。记录人口统计学数据以及伴随症状,如疲劳、抑郁、焦虑、肠道功能障碍、泌尿问题和行走状态。

结果

共纳入228例病例。其中183例为女性(80.3%),45例为男性(19.7%)(女性/男性比例 = 4)。ABSST平均得分为6.8±5.7。根据临界值8,83例(28.8%)有可行动膀胱症状(36.4%)。ABSST≥8组的平均年龄和病程显著更高。第二组中尿潴留、滴尿和尿失禁患者的数量显著更高,而第一组(ABSST<8)中无需帮助即可行走的个体数量显著更高。以ABSST得分小于或大于8为因变量,年龄、性别、病程、婚姻状况、教育水平和BMI为自变量进行逻辑回归分析表明,年龄、教育水平和病程是独立预测因素。

结论

根据这些结果,近三分之一的伊朗多发性硬化症患者患有膀胱过度活动症,医生应予以考虑。

相似文献

1
Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.
J Multidiscip Healthc. 2020 Apr 2;13:345-349. doi: 10.2147/JMDH.S244697. eCollection 2020.
2
Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis.
Neurourol Urodyn. 2020 Jan;39(1):243-252. doi: 10.1002/nau.24177. Epub 2019 Oct 6.
3
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
Int Urogynecol J. 2014 Dec;25(12):1655-63. doi: 10.1007/s00192-014-2417-7. Epub 2014 May 24.
4
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
Neurourol Urodyn. 2017 Apr;36(4):1208-1213. doi: 10.1002/nau.23101. Epub 2016 Aug 22.
5
Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis.
J Multidiscip Healthc. 2020 Jan 17;13:79-83. doi: 10.2147/JMDH.S236275. eCollection 2020.
6
7
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
Int J MS Care. 2013 Winter;15(4):182-92. doi: 10.7224/1537-2073.2012-049.
8
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis.
Int Neurourol J. 2021 Dec;25(4):310-318. doi: 10.5213/inj.2040346.173. Epub 2021 May 6.

引用本文的文献

本文引用的文献

1
Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis.
J Multidiscip Healthc. 2020 Jan 17;13:79-83. doi: 10.2147/JMDH.S236275. eCollection 2020.
3
Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Public Health. 2019 Oct;175:138-144. doi: 10.1016/j.puhe.2019.07.013. Epub 2019 Aug 30.
4
Pain in Patients with Multiple Sclerosis.
Maedica (Bucur). 2018 Jun;13(2):125-130. doi: 10.26574/maedica.2018.13.2.125.
5
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Eur J Neurol. 2016 Jul;23(7):1228-34. doi: 10.1111/ene.13010. Epub 2016 Apr 27.
6
Management of neurogenic bladder in patients with multiple sclerosis.
Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31.
9
Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.
J Spinal Cord Med. 2016;39(2):229-33. doi: 10.1179/2045772315Y.0000000021. Epub 2016 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验